Spotlight
Video

Axitinib Phase 3 Trial, Dr. Brian Rini MD on whether the patients would be considered low, intermediate or high risk by the Motzer Prognostic Scoring System

videoblog has 63 videos Subscribe Here

Loading........
Description: Axitinib Phase 3 Trial, Dr. Brian Rini MD on whether the patients would be considered low, intermediate or high risk by the Motzer Prognostic Scoring System. ASCO 2011
Shared By : videoblog
Posted on : 06/06/11
Added : 6 years ago
Category : General



More From videoblog

Nothing found.